Veterinary Medicines

Bupredine Multidose 0.3 mg/ml Solution for Injection for Dogs, Cats and Horses

Authorised
  • Buprenorphine
Download as PDF

Product identification

Medicine name:
Bupredine Multidose 0.3 mg/ml Solution for Injection for Dogs, Cats and Horses
Bupredine Multidose 0.3 mg/ml Oplossing voor injectie
Bupredine Multidose 0.3 mg/ml Solution injectable
Bupredine Multidose 0.3 mg/ml Injektionslösung
Active substance:
  • Buprenorphine
Target species:
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine
    0.30
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Horse
    • Cat
  • Intravenous use
    • Dog
    • Horse
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Clear type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box. Pack size: 20 ml.
  • Clear type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box. Pack size: 100 ml
  • Clear type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box. Pack size: 10 ml.
  • Clear type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box. Pack size: 50 ml
  • Clear type I glass vials closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box. Pack size: 5 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V480444
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0314/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."